DOI:
10.1055/s-00000029
Journal of Reconstructive Microsurgery
LinksClose Window
References
Joseph RW, Elassaiss-Schaap J, Kefford R. , et al.
Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab.
Clin Cancer Res 2018;
24 (20) 4960-4967
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.